Skip to main content

IB10 sphingotest® D-Dimer


IB10 sphingotest® D-Dimer is a rapid point-of-care (POC) immunoassay for the quantitative in vitro determination of cross-linked fibrin degradation products containing D-Dimer in Lithium-Heparin or Citrate whole blood or plasma.

The test is designed for professional use only and may be used on sites where near patient testing is practiced.

Cat No. IVR-IB52 | D-Dimer (package of 10 discs)

Clinical Significance

D-Dimer determinations aid in the quantitative assessment and evaluation of patients presenting with clinical symptoms of venous thromboembolism (VTE) including severely evolving disseminated intravascular coagulation, pulmonary embolism and deep vein thrombosis. Values at or below the upper limit of a healthy reference population are highly predictive of exclusion of VTE as a cause of symptoms (1,2,3,4).

Expected Values

From a population of 244 individuals, the IB10 sphingotest® D-Dimer test was used to determine the concentration upper reference limit of D-Dimer. This population included apparently healthy individuals. The 95th percentile upper reference limit, using lithium heparin as anticoagulant, is 446.8 FEU ng/mL. The IB10 sphingotest® D-Dimer reports results in FEU ng/mL. It is comonly accepted that 1 D-DU is equal to 2 FEU.

Each laboratory should establish a reference range that represents the patient population that is to be evaluated at their facility.


 

Whole Blood vs. Plasma Comparison

All our assays correlate with r=0.9. For more detailed information please read the IFUs or connect with our sales representatives.

 


 

Key Features

Easy Handling
Sample TypeLithium-Heparin or Citrate Whole Blood and Plasma Samples
Time to Result20 minutes
Measuring Range100 - 4,000 FEU ng/mL
Limit of Detection 100 FEU ng/mL
No High Dose Hook Effectup to 40,000 FEU ng/mL
Analyte Stability for IB10 Measurement24 hours for whole blood

 

Request a quote

 IB10 sphingotest® D-Dimer is a rapid point-of-care (POC) immunoassay for the quantitative in vitro determination of crosslinked fibrin degradation products containing D-Dimer in Lithium-Heparin or Citrate whole blood or plasma.

Request a Quote


References

(1) Riley RS et al. Widely Used Types and Clinical Applications of D-Dimer Assay. Lab Med. 2016 May;47(2):90-102.
(2) Song J et al. Analytical and clinical performance of a new point of care LABGEOIB D-dimer test for diagnosis of venous thromboembolism. Ann Clin Lab Sci. 2014 Summer;44(3):254-61.
(3) Price CP et al. Point-of-Care Testing for D-Dimer in the Diagnosis of Venous Thromboembolism in Primary Care: A Narrative Review. Cardiol Ther 2020.
(4) Kyrle PA et al. Deep vein thrombosis. Lancet. 2005 Mar 26-Apr 1;365(9465):1163-74.